TY - JOUR
T1 - Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells
AU - Sherman-Baust, Cheryl A.
AU - Weeraratna, Ashani T.
AU - Rangel, Leticia B.A.
AU - Pizer, Ellen S.
AU - Cho, Kathleen R.
AU - Schwartz, Donald R.
AU - Shock, Teresa
AU - Morin, Patrice J.
PY - 2003/4
Y1 - 2003/4
N2 - The mechanisms of drug resistance in cancer are poorly understood. Serial analysis of gene expression (SAGE) profiling of cisplatin-resistant and sensitive cells revealed many differentially expressed genes. Remarkably, many ECM genes were elevated in cisplatin-resistant cells. COL6A3 was one of the most highly upregulated genes, and cultivation of cisplatin-sensitive cells in the presence of collagen VI protein promoted resistance in vitro. Staining of ovarian tumors with collagen VI antibodies confirmed collagen VI expression in vivo and suggested reorganization of the extracellular matrix in the vicinity of the tumor. Furthermore, the presence of collagen VI correlated with tumor grade, an ovarian cancer prognostic factor. These results suggest that tumor cells may directly remodel their microenvironment to increase their survival in the presence of chemotherapeutic drugs.
AB - The mechanisms of drug resistance in cancer are poorly understood. Serial analysis of gene expression (SAGE) profiling of cisplatin-resistant and sensitive cells revealed many differentially expressed genes. Remarkably, many ECM genes were elevated in cisplatin-resistant cells. COL6A3 was one of the most highly upregulated genes, and cultivation of cisplatin-sensitive cells in the presence of collagen VI protein promoted resistance in vitro. Staining of ovarian tumors with collagen VI antibodies confirmed collagen VI expression in vivo and suggested reorganization of the extracellular matrix in the vicinity of the tumor. Furthermore, the presence of collagen VI correlated with tumor grade, an ovarian cancer prognostic factor. These results suggest that tumor cells may directly remodel their microenvironment to increase their survival in the presence of chemotherapeutic drugs.
UR - http://www.scopus.com/inward/record.url?scp=0141484480&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0141484480&partnerID=8YFLogxK
U2 - 10.1016/S1535-6108(03)00058-8
DO - 10.1016/S1535-6108(03)00058-8
M3 - Article
C2 - 12726863
AN - SCOPUS:0141484480
SN - 1535-6108
VL - 3
SP - 377
EP - 386
JO - Cancer Cell
JF - Cancer Cell
IS - 4
ER -